American Journal of Transplantation

Article	Citations
Outside Front Cover	309
American Journal of Transplantation: Volume 21, Number 7, July 2021	297
OFC 23rd Winter Symposium	281
AJT Digest for Patients: Their Own Window into Key Research	273
Dual Kidney Transplantation from Extended Marginal Donors in the United States: An analysis of SRTR and Literature Review	205
Benefits Of Preemptive Transplantation In Older Patients with High KDPI Kidneys: Is Sooner Better Than Later?	203
Disparities in liver transplantation: One size may not fit all	196
Are we closer to abandoning protocol graft biopsies after pediatric liver transplantation?	176
Rethinking Lactate’s Role as a Post-Transplant Outcome Predictor During Normothermic Machine Perfusion: Science or Speculation?	142
Optimization of donor flow matching and portal modulation to decrease small for size syndrome in Living Donor Liver Transplant - A Single Center American Experience	131
Deceased Kidney Donors on Dialysis Create Opportunities for Renal Transplantation: A Single Center Experience	130
Outcomes By Epstein-Barr Virus Serostatus In Pediatric Kidney Transplantation	126
Microbiota and immunoregulation: A focus on regulatory B lymphocytes and transplantation	118
Recurrence of membranous nephropathy after kidney transplantation: A multicenter retrospective cohort study	113
Disulfide-HMGB1 signals through TLR4 and TLR9 to induce inflammatory macrophages capable of innate-adaptive crosstalk in human liver transplantation	112
Long-term outcomes after normothermic machine perfusion in liver transplantation—Experience at a single North American center	111
Induction of fetomaternal tolerance? Suppressing B cells!	108
Hereditary thrombotic thrombocytopenic purpura acquired through liver transplantation: A case report	105
De novo membranous nephropathy in a pig-to-baboon kidney xenograft: A new xenograft glomerulopathy	105
Pediatric cardiac xenotransplantation and stakeholder engagement	104
Increasing Azole-resistant environmental Aspergillus fumigatus in Denmark	103
International multicenter study of ultralow graft-to-recipient weight ratio grafts in adult living donor liver transplantation	95
Will the flu vaccine work this year?	93
Phage-display immunoprecipitation for precision mapping the autoreactome	93
SARS-CoV-2 antibody testing for transplant recipients: A tool to personalize protection versus COVID-19	92

Kaposi sarcoma herpesvirus inflammatory cytokine syndrome—a severe complication of an overlooked donor-derived infection	92
Accurate eplet identification is necessary for accurate risk assessment	90
Rituximab for recurrence of primary focal segmental glomerulosclerosis after kidney transplantation: Results of a nationwide study	82
Epidemiology and outcomes of bone and joint infections in solid organ transplant recipients	81
Impact of interleukin-6 on T cells in kidney transplant recipients	77
Alloantibodies after simultaneous liver-kidney transplant: A story of primary nonfunction, retransplantation, and antibody-mediated rejection	75
OPTN/SRTR 2021 Annual Data Report: COVID-19	74
Navigating challenges in recipient selection for end-chain kidneys	74
New metrics to measure OPO performance are here: How do we ensure organizations receive feedback and improve organ donation?	74
Dynamic impact of liver allocation policy change on donor utilization	73
Short-course early outpatient remdesivir prevents severe disease due to COVID-19 in organ transplant recipients during the omicron BA.2 wave	71
Effects of in vivo CXCR4 blockade and proteasome inhibition on bone marrow plasma cells in HLA-sensitized kidney transplant candidates	68
Efficiency of a boost with a third dose of anti-SARS-CoV-2 messenger RNA-based vaccines in solid organ transplant recipients	66
The role of interleukin-21 in COVID-19 vaccine–induced B cell–mediated immune responses in patients with kidney disease and kidney transplant recipients	66
Development of a natural language processing algorithm to extract social determinants of health from clinician notes	66
The benefit to waitlist patients in a national paired kidney exchange program: Exploring characteristics of chain end living donor transplants	66
Weak antibody response to three doses of mRNA vaccine in kidney transplant recipients treated with belatacept	66
Generating strategies for a national comeback in pancreas transplantation: A Delphi survey and US conference report	65
An ethical analysis of conditional and partially directed live kidney donation among strangers—The Israeli experience	64
Adjunctive glucocorticoid therapy for Pneumocystis jirovecii pneumonia in solid organ transplant recipients: A multicenter cohort, 2015-2020	64
Polymicrobial bacteremia in a heart transplant recipient: More than what meets the eye	64
Eculizumab as a therapeutic approach for severe crescentic recurrence of immunoglobulin A nephropathy after kidney transplantation	64
First case of rapidly fatal mpox from secondary (household) transmission in a kidney transplant recipient	62
Rejection and graft vasculopathy secondary to effects of Crohn's disease in a heart-transplanted child	62
OPTN/SRTR 2021 Annual Data Report: Lung	61
Atezolizumab plus bevacizumab as a downstaging therapy for liver transplantation in hepatocellular carcinoma with portal vein thrombosis: The first report	61
Short- and long-term complications after living donor ileal resection	61
Validation of a novel donor lung scoring system based on the updated lung Composite Allocation Score	61
Comparative outcomes for over 100 deceased donor kidney transplants from SARS-CoV-2 positive donors: A single-center experience	61
Pure laparoscopic donor hepatectomy: Experience of 556 cases at Seoul National University Hospital	60
DCDD heart transplantation with thoraco-abdominal normothermic regional perfusion and static cold storage: The experience in Spain	59
Association of antiviral prophylaxis and rituximab use with posttransplant lymphoproliferative disorders (PTLDs): A nationwide cohort study	59
Corrigendum to ‘Partial Bladder Transplantation with En Bloc Kidney Transplant—The First Case Report of a ‘Bladder Patch Technique’ in a Human’ [American Journal of Transplantation 8 (2008) 1060-1063]	57
A plan to save lives: Hong Kong–mainland China second-tier mutual assistance allocation	57
Prevention of Mollicute transmitted infections from donor lungs after lung transplant	54
Increasing liver organ acquisition fees and the risk of a tragedy of the commons	54
Anatomical variations of left hepatic vein and outflow reconstruction techniques in pediatric living donor liver transplantation	54
10 degree C static storage of porcine donation after circulatory death livers improves biliary viability and mitigates ischemia-reperfusion injury	54
Donor programmed cell death 1 ligand 1 is required for organ transplant tolerance in major histocompatibility complex-mismatched mixed chimeras although programmed cell death 1 ligand 1 and major hist	53
Specific human leucocyte antigen-DQ risk epitope mismatches are associated with chronic lung allograft dysfunction after lung transplantation	52
Effectiveness of a culturally competent care intervention in reducing disparities in Hispanic live donor kidney transplantation: A hybrid trial	52
Sex disparity in liver allocation within Eurotransplant	52
Negative immune responses to two-dose mRNA COVID-19 vaccines in renal allograft recipients assessed with simple antibody and interferon gamma release assay cellular monitoring	51
The dangerous precedent of censoring scientific dissemination	50
Regarding normothermic regional perfusion: Arguing by insistence is not a strong argument	50
Body composition and the skeletal muscle compartment in liver transplantation: Turning challenges into opportunities	50
ATC 2024 Poster Abstracts	50
Rhabdomyolysis Following Living Donor Kidney Donation - an Underreported Entity?	49
DCD Liver Transplantation- Contemporary US Experience with NRP and NMP	49
Characterizing Renal Function Predictors and Outcomes in Liver Transplant Recipients Who Have Preoperative Renal Dysfunction	49

One Man In His Time Plays Many Parts: Transplant Surgeons’ Approach to Evolution of Career Identity	49
Intranasal therapy of IGFBP2 ameliorates lung fibrosis	48
Poor Post-Transplantation Renal Function Negatively Impacts Survival of Liver Transplant Recipients Despite SLK and Safety Net Kidney Transplantation	48
Integrating frailty into clinical care	47
Variability in post-transplant outcomes reported by studies examining perfusion techniques in liver transplantation: a qualitative systematic review	47
Controlled Hypothermic Preservation of Donor Livers with Back- to-Base Normothermic Machine Perfusion Improves Clinical Outcomes and Facilitates Donor Pool Expansion	47
Cell-free DNA method for monitoring porcine-to-human xenotransplants	47
Characterizing proximity and transfers of deceased organ donors to donor care units in the United States	46
Sowing “seeds of trust”: How trust in normothermic regional perfusion is built in a continuum of care	46
CDC guidance on new pentavalent meningococcal vaccine	46
Substantial weight loss resulting in a large panniculus may incur additional pretransplant costs	45
Adjusting for race in metrics of organ procurement organization performance	45
The impact of machine perfusion of the heart on warm ischemia time and organ yield in donation after circulatory death	45
First report of auxiliary liver transplantation for severe cholangiopathy after SARS-CoV-2 respiratory infection	44
MELD-based allocation at 20: Can we evolve and mature?	43
SARS-CoV-2 vaccine effectiveness trumps immunogenicity in solid organ transplant recipients	43
Second field high-resolution HLA typing for immunologic risk stratification in kidney transplantation	43
Utilization and outcomes of deceased donor SARS-CoV-2–positive organs for solid organ transplantation in the United States	42
Novel modified iliac artery stent graft with side branch extension facilitating kidney transplant in severe aortoiliac occlusive disease	42
The effect of cholecalciferol supplementation on allograft function in incident kidney transplant recipients: A randomized controlled study	42
Geographic disparities in access to liver transplant for advanced cirrhosis: Time to ring the alarm!	42
Unexpected incidental finding in a prospective living kidney donor	41
Incomplete tissue product tracing during an investigation of a tissue-derived tuberculosis outbreak	40
Back-table intra-arterial administration of C1 esterase inhibitor to deceased donor kidney allografts improves posttransplant allograft function: Results of a randomized double-blind placebo-controlle	39
“Time is tissue”—A minireview on the importance of donor nephrectomy, donor hepatectomy, and implantation times in kidney and liver transplantation	39
“Horses for courses” computed tomography or predicted total lung capacity for size matching in lung transplantation	39
Donor utilization in heart transplant with donation after circulatory death in the United States	39
The short end of the stick: Access to lung transplantation for short-statured patients in the composite allocation score era	38
OPTN/SRTR 2023 Annual Data Report: Lung	38
Normothermic ex situ pancreas perfusion for the preservation of porcine pancreas grafts	38
OPTN/SRTR 2023 Annual Data Report: Kidney	38
Efficacy of ceftazidime-avibactam in solid organ transplant recipients with bloodstream infections caused by carbapenemase-producing Klebsiella pneumoniae	38
Utilizing pathophysiological concepts of ischemia-reperfusion injury to design renoprotective strategies and therapeutic interventions for normothermic ex vivo kidney perfusion	38
Changes in influenza and other respiratory virus activity during the COVID-19 pandemic—United States, 2020–2021	38
Down to the coronary arteries: When spatial multiomics open up a narrow path	37
Oxidative stress and related metabolic alterations are induced in ex situ perfusion of donated hearts regardless of the ventricular load or leukocyte depletion	37
Spatial multiomics of arterial regions from cardiac allograft vasculopathy rejected grafts reveal novel insights into the pathogenesis of chronic antibody-mediated rejection	37
Robotic kidney transplantation from deceased donors: A single-center experience	37
Immunosuppressive therapy after solid organ transplantation and the gut microbiota: Bidirectional interactions with clinical consequences	36
	36
Stem cell–derived islets take a leap toward patients	36
The 21st Century Cures Act and psychosocial electronic documentation in solid organ transplantation: Potential harms and practical strategies	35
Treating comorbidity in solid organ transplant recipients as a confounder or a mediator of patient outcomes	35
Macrophage-inducible C-type lectin activates B cells to promote T cell reconstitution in heart allograft recipients	35
Targeting CXCR1/2 in the first multicenter, double-blinded, randomized trial in autologous islet transplant recipients	35
Low-dose interleukin-2 promotes immune regulation in face transplantation: A pilot study	35
Continuous donor-recipient age matching: A chance for kidney allocation in the Eurotransplant region	34
Effectiveness of SARS-CoV-2 vaccination in fully vaccinated solid organ transplant recipients	34
Subphenotypes of frailty in lung transplant candidates	34
Protecting kidney transplant recipients against SARS-CoV-2 infection: A third dose of vaccine is necessary now	34
Oropouche virus disease—region of the Americas	34
Balancing the live virus vaccine scales: Protection vs risk	33
Trained immunity: Can we get one transplanted kidney to last a lifetime?	33
Pancreas transplantation as rescue therapy in a patient with type 1 diabetes and concurrent subcutaneous insulin resistance	33
Prognostic implications of lung cancers incidentally identified on explant: A joint study of the Scientific Registry of Transplant Recipients and the National Cancer Database	33
A 46-year-old male with posttransplant lymphoproliferative disorder and massive hemoptysis following second bilateral lung transplantation	33
Facial skin lesions and diarrhea in a kidney transplant recipient	33
Utilizing kidneys from a donor with bile-cast nephropathy	33
Keep the engine running: Maintaining transplant registry utility in liver transplant	32
POST-TRANSPLANT LYMPHOPROLIFERATIVE DISORDERS 2nd Edition Dharnidharka Vikas R, Green Michael, Webber Steven A, Ulrich Trappe Ralf (ed.), Switzerland: Springer International Publishing, 2021, XIII, 31	32
The current state of transplant advanced practice providers: results of the advanced practice provider practice survey	32
Upper gastrointestinal bleeding in a lung transplant recipient	32
Dual JAK2/Aurora kinase A inhibition prevents human skin graft rejection by allo-inactivation and ILC2-mediated tissue repair	32
Outside Front Cover	32
Transplant oncology in locally advanced intrahepatic cholangiocarcinoma: One more step on a long road	32
OPTN/SRTR 2022 Annual Data Report: COVID-19	32
Outcomes of Single Pediatric Kidney Grafts	31
Front Page	31
Circadian clocks drive rhythmic antitumor immune responses mediated by migratory dendritic cells	31
The impact of visitation volunteers on the mood, valence, and arousal of liver and kidney transplant patients	31
What Can We Learn from analyzing Paired Mate Kidneys Transplanted at the Same Center?	31
OPTN/SRTR 2021 Annual Data Report: Deceased Organ Donation	31
The Role of Race and Socioeconomic Status in Live Donor Kidney Transplant Interest and Evaluation	31
AWAKE Program with rapid discharge in Kidney Transplantation	31
Generalizability of kidney transplant data in electronic health records — The Epic Cosmos database vs the Scientific Registry of Transplant Recipients	31
Total pancreatectomy with islet cell autotransplantation in a 2-year-old child with hereditary pancreatitis due to a PRSS1 mutation	30
The landscape of hepatitis C virus infection in pediatric kidney transplantation	30
CD47 and PD-L1 overexpression in proliferating human hepatocytes attenuated immune responses and ameliorated acute liver injury in mice	30
Hemophagocytic syndrome with graft-versus-host disease after liver transplantation: The bone marrow as a not so quiet battlefield?	30
In a real-life setting, risk factors, coronary artery calcium score, and coronary stenosis at computed tomography angiography are associated with major adverse cardiovascular events and all-cause mort	29

Liver transplantation for acute liver failure and acute-on-chronic liver failure	29
Clear data, careful counseling: Discussing cancer risk after living kidney donation	29
Transplantation, HIV Serostatus, and Registry Data: Room for Improvement	29
Characteristics and Outcomes Among Adults Aged ≥60 Years Hospitalized with Laboratory-Confirmed Respiratory Syncytial Virus — RSV-NET, 12 States, July 2022–June 2023	29
Interleukin 6 trans-signaling is a critical driver of lung allograft fibrosis	29
Motivations and outcomes of compatible living donor–recipient pairs in paired exchange	28
TIGIT agonism alleviates costimulation blockade-resistant rejection in a regulatory T cell–dependent manner	28
Molecular diagnosis of antibody-mediated rejection: Evaluating biopsy-based transcript diagnostics in the presence of donor-specific antibodies but without microvascular inflammation, a single-center	28
OPTN/SRTR 2020 Annual Data Report: Lung	28
Impact of the new UNOS donor heart allocation system on waitlist outcomes and early posttransplant mortality among adults with congenital heart disease	28
Letermovir in lung transplant recipients with cytomegalovirus infection: A retrospective observational study	28
FGFR2 rearrangement intrahepatic cholangiocarcinoma: The potential efficacy of pemigatinib and long-term questions about the transplantation bridge strategy	28
The living organ donor as patient: Theory and practice	27
	27
The thymus hosts liver- and gut-like mimetic cells critical to immune self-tolerance	27
Effects of broader geographic distribution of donor lungs on travel mode and estimated costs of organ procurement	27
	27
The individual impact of machine perfusion on liver and kidney in simultaneous liver and kidney transplantation	26
Managing Bile Duct and Vascular Variations in Robotic Assisted Living Donor Right Hepatectomy: A Single Center U.S. Experience	26
Importance of malnutrition and frailty in kidney transplant waiting list	26
Impact of Normothermic Machine Perfusion on Liver Transplant Waitlist Times: A Single-Center Matched Cohort	26
The Comparison of Cellular and Acellular Perfusate for the Dynamic Organ Storage System in a Porcine Donation After Circulatory Death Model	26
When is it safe to transplant after cancer–adding data to the decision	26
Outcomes in Patients with Incidental Intra-hepatic Cholangiocarcinoma on Explant Pathology after Liver Transplantation	26
Bioengineered Organs: Not a Matter of “If”	26
The role of IL-6 in hyperlipidemia-induced accelerated rejection	25
Evaluation for genetic disease in kidney transplant candidates: A practice resource	25
Graft function and incidence of cardiac allograft vasculopathy in donation after circulatory-determined death heart transplant recipients	25
The molecular phenotypes of injury, steatohepatitis, and fibrosis in liver transplant biopsies in the INTERLIVER study	25
Deceased donor urinary Dickkopf-3 associates with future allograft function following kidney transplantation	25
OPTN/SRTR 2023 Annual Data Report: Intestine	25
Correcting the sex disparity in MELD-Na	25
The concept of immunothrombosis in pancreas transplantation	25
Bringing palliative care to transplant	25
Mortality among solid organ transplant recipients with a pretransplant cancer diagnosis	25
Tongue ulcer in a pediatric heart transplant recipient	24
From flawed to fairer: Reducing blood type bias in lung transplant allocation	24
Humoral immune responses against SARS-CoV-2 in transplantation: Actionable biomarker or misplaced trust?	24
Diagnosis and treatment of allograft rejection in islet transplantation	24
Belatacept-related cytomegalovirus infection: Advocacy for tailored immunosuppression based on individual assessment of immune fitness	24
White paper on antimicrobial stewardship in solid organ transplant recipients	24
Gene expression–based molecular scoring of pancreas transplant rejection for a quantitative assessment of rejection severity and resistance to treatment	24
Preformed T cell alloimmunity and HLA eplet mismatch to guide immunosuppression minimization with tacrolimus monotherapy in kidney transplantation: Results of the CELLIMIN trial	24
Surgical site infections after kidney transplantation are independently associated with graft loss	23
The role of bypass filters in deceased donor kidney allocation in the United States	23
Graft-resident donor macrophages functionally regulate transplant outcomes	23
Augmenter of liver regeneration-mediated mitophagy protects against hepatic ischemia/reperfusion injury	23
Solid organ transplant recipients with tuberculosis disease in California, 2010 to 2020	23
Unexpected hepatitis B virus infection after liver transplantation — United States, 2014–2019	23
A rational approach to guide cost-effective de novo donor-specific antibody surveillance with tacrolimus immunosuppression	23
Donor-specific immune senescence as a candidate biomarker of operational tolerance following liver transplantation in adults: Results of a prospective, multicenter cohort study	23
Iron deficiency, anemia, and patient-reported outcomes in kidney transplant recipients	23
OPTN/SRTR 2022 Annual Data Report: Heart	23
American Journal of Transplantation: Volume 21, Number 10, October 2021	23
Severe relapse of SARS-CoV-2 infection in a kidney transplant recipient with negative nasopharyngeal SARS-CoV-2 RT-PCR after rituximab	23
A third dose of SARS-CoV-2 vaccine increases neutralizing antibodies against variants of concern in solid organ transplant recipients	23
ATC 2023 DAAG_Program	22
Characteristics and Outcomes of Kidneys Accepted versus Turned Down by Regional Centers	22
Corrigendum to ‘Assessment of long-term outcomes post living liver donation highlights the importance of scientific integrity when presenting transplant registry data’ [American Journal of Transplanta	22
Orthotopic robot-assisted laparoscopic kidney transplantation with living donor: An option for patients excluded from standard heterotopic transplantation	22
American Journal of Transplantation: Volume 22, Number 2, February 2022	22
Transplantation pushes into the world of elite sports	22
Expedited lung allocation in the era of continuous distribution	22
Corrigendum to ‘Criteria for prediabetes and posttransplant diabetes mellitus after kidney transplantation: A 2-year diagnostic accuracy study of participants from a randomized controlled trial’ [Amer	22
T Cell repopulation after using rATG in a Decedent Xenotransplant Study	22
Multivisceral transplantation utilizing hepatitis C virus–viremic donors for hepatitis C virus–negative recipients	22
Therapeutic Hypothermia vs Normothermia in Kidney Transplantation: A Meta-analysis of Randomized Controlled Trials	22
Book review	22
Macrophage-specific hypoxia inducible factor 2α expression promotes cardiac allograft tolerance	22
BK DNAemia and native kidney polyomavirus nephropathy following lung transplantation	21
First case report of multivisceral transplant from a deceased cardiac death donor	21
Repeat SARS-CoV-2 testing after recovery. Is a pretransplant PCR necessary?	21
Caregiver COVID-19 vaccination for solid organ transplant candidates	21
Preemptive intravenous human immunoglobulin G suppresses BK polyomavirus replication and spread of infection in vitro	21
OPTN/SRTR 2021 Annual Data Report: Introduction	21
Time to reconsider the role of donor hepatitis C status in the Kidney Donor Risk Index	21
Liver Transplantation for Fulminant Hepatic Failure in a Young Woman	21
OPTN/SRTR 2022 Annual Data Report: Intestine	21
Chimeric autoantibody-receptor T cells mediate depletion of autoantibody-producing B cells	21
Wanted: An endothelial cell targeting atlas for nanotherapeutic delivery in allograft organs	21
Hepatitis C–associated focal proliferative glomerulonephritis in an aviremic recipient of a hepatitis C–positive antibody donor liver	20
Response to “Public attitude to imminent death donation”	20
Banff and ABMR: Are we going in the right direction?	20
Partial bladder transplantation with en bloc kidney transplant—long-term, 17 years, the outcome of a “bladder patch technique”	20
Normothermic regional perfusion in donation after circulatory determination of death—Confirming the absence of brain reperfusion	20
Normothermic Machine Perfusion Facilitates Donation After Circulatory Death Liver Transplant In High-Risk Recipients	20
Multiple liver lesions in a lung transplant recipient	20
Association of transplant center market concentration and local organ availability with deceased donor kidney utilization	20
Memory T follicular helper cells drive donor-specific antibodies independent of memory B cells and primary germinal center and alloantibody formation	20
Association of organ procurement organization volume with Centers for Medicare and Medicaid Services performance evaluations	20
Graft-versus-host disease after liver transplantation is associated with bone marrow failure, hemophagocytosis, and DNMT3A mutations	20
The impact of islet mass, number of transplants, and time between transplants on graft function in a national islet transplant program	20
OPTN/SRTR 2022 Annual Data Report: Pancreas	20
Recipient sex and estradiol levels affect transplant outcomes in an age-specific fashion	20
OPTN/SRTR 2022 Annual Data Report: Deceased Organ Donation	19